Yellow fever risk assessment in the Central African Republic

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 108, Issue 10, 2014, Pages 608-615

  Staples, J Erin ^a   Diallo, Mawlouth ^b   Janusz, Kristen B ^a   Manengu, Casimir ^c   Lewis, Rosamund F ^c   Perea, William ^c   Yactayo, Sergio ^c   Sall, Amadou A ^b   Balekouzou, Augustin ^d   Gamba, Eddy Patrick ^d   Gbatoumba, Virginie ^d   Guezza, Dieudonné ^d   Kobangue, Léon ^d   Kounda Gboumbi, Jean Charles ^d   Louango, Elie Didier ^d   Malemoko, Grégorie ^d   Nangouma, Auguste ^d   Opandy, Guy Chantal ^d   Ouambita Mabo, Rock ^d   Pounguinza, Simon ^d   Sendazo, Joseph ^d   Wata, Jean Bertrand ^d   Passi, Franklin Danague ^d   Gnikoli, Barthélémy ^d   Gokra, Adolphe Hilaire ^d   Mal Mal, Essène Hamat ^d   Ngoutendji, Abel ^d   Gouandijka Vasilache, Ionela ^e   Konamna, Xavier ^e   Laganier, Rémi ^e   Sélekon, Benjamin ^e   Conjugo, Peggy ^c   Kamba, Alexis ^c   Ruhana, Mirindi ^c   more..

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d FCA UNESP   (Brazil)

^e INSTITUT PASTEUR DE BANGUI   (Central African Republic)

Author keywords

Aedes mosquitos; Central African Republic; Enzyme linked immunosorbent assay; Reverse transcriptase polymerase chain reaction; Yellow fever; Yellow fever virus

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AEDES AEGYPTI; ARTICLE; CENTRAL AFRICAN REPUBLIC; CHILD; DISEASE SURVEILLANCE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HUMAN; INFANT; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; PRIMATE; PUBLIC HEALTH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; URBAN AREA; VACCINATION; YELLOW FEVER; YELLOW FEVER VIRUS; AEDES; ANIMAL; CLUSTER ANALYSIS; DISEASE CARRIER; GENETICS; HEALTH SURVEY; IMMUNOLOGY; ISOLATION AND PURIFICATION; PRIMATE DISEASES; VIROLOGY;

AEDES; ANIMALS; ANTIBODIES, VIRAL; CENTRAL AFRICAN REPUBLIC; CLUSTER ANALYSIS; HUMANS; INSECT VECTORS; POPULATION SURVEILLANCE; PRIMATE DISEASES; PRIMATES; RISK ASSESSMENT; RNA, VIRAL; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 84929502935     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/tru086     Document Type: Article

References (31)

1. Monath TP, Gershman M, Staples JE, Barrett ADT. Yellow fever vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia, PA: Elsevier Saunders; 2013.
2. World Health Organization. Vaccines and vaccination against yellow fever. WHO position paper-June 2013. Wkly Epidemiol Rec 2013;88:269-83.
3. Ellis BR, Barrett AD. The enigma of yellow fever in East Africa. Rev Med Virol 2008;18:331-46.
4. Digoutte JP. Yellow fever in Central Africa [in French]. Cah ORSTOM Ser Ent Med Parasitol 1972;10:145-54.
5. Chippaux-Hyppolite C, Chippaux A. Yellow fever antibodies among children in the Central African Republic [in French]. Bull World Health Organ 1966;34:105-11.
6. Mathiot CC, Gonzalez JP, Georges AJ. Current problems of arboviruses in central Africa [in French]. Bull Soc Pathol Exot Filiales 1988;81: 396-401.
7. World Health Organization. Reported estimates of immunization coverage time series: Yellow fever vaccine. 2013. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoverageyfv.html [accessed 14 May 2014].
8. World Health Organization. Yellow Fever in the Central African Republic. 2009. http://www.who.int/csr/don/2009_12_01/en/index.html [accessed 15 July 2013].
9. World Health Organization. Update on progress controlling yellow fever in Africa, 2004-2008. Wkly Epidemiol Rec 2008;83:450-8.
10. Geoffroy B, Cordellier R. Observation on potential vectors of yellow fever in Central African Republic [in French]. Cah ORSTOM, Ser Ent Med et Parasitol 1972;10:127-44.
11. Saluzzo JF, Ivanoff B, Languillat G, Georges AJ. Serological survey for arbovirus antibodies in the human and simian populations of the South-East of Gabon (author's transl) [in French]. Bull Soc Pathol Exot Filiales 1982;75:262-6.
12. Diallo M, Laganier R, Nangouma A. First record of Ae. albopictus (Skuse 1894), in Central African Republic. Trop Med Int Health 2010;15: 1185-9.
13. World Health Organization. HIV/AIDS Epidemiological Surveillance Report for the WHO African Region: 2007 Update. http://www.who.int/hiv/pub/me/afro_epi_sur_2007.pdf [accessed 2 December 2013].
14. Faye O, Diallo M, Dia I et al. Integrated approach to yellow fever surveillance: pilot study in Senegal in 2003-2004 [in French]. Bull Soc Pathol Exot 2007;100:187-92.
15. Sureau P, Jaeger G, Pinerd G et al. Sero-epidemiological survey of arbovirus diseases in the Bi-Aka pygmies of Lobaye, Central African Republic [in French]. Bull Soc Pathol Exot Filiales 1997;70:131-7.
16. Niedrig M, Lademann M, Emmerich P, Lafrenz M. Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Trop Med Int Health 1999;4:867-71.
17. Centers for Disease Control and Prevention. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010;59:1-27.
18. Weidmann M, Faye O, Faye O et al. Improved LNA probe-based assay for the detection of African and South American yellow fever virus strains. J Clin Virol 2010;48:187-92.
19. WHO. Dengue: Guidelines for diagnosis, treatment, prevention, and control. Geneva, Switzerland: World Health Organization. http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf [accessed 15 July 2013].
20. Bang YH, Bown DN, Onwubiko AO. Prevalence of larvae of potential yellow fever vectors in domestic water containers in south-east Nigeria. Bull World Health Organ 1981;59:107-14.
21. Germain M, Mouchet J, Cordellier R et al. Epidemiology of yellow fever in Africa in French]. Med Mal Infect 1978;2:69-77.
22. Beeuwkes H, Mahaffy AF, Burke AW, Paul JH. Yellow fever protection test surveys in the French Cameroons, French Equitorial Africa, the Beglian Congo, and Angola. Trans R Soc Trop Med Hyg 1934;28:233-58.
23. Saluzzo JF, Gonzalez JP, Herve JP, Georges AJ. Serological survey for the prevalence of certain arboviruses in the human population of the south-east area of Central African Republic [in French]. Bull Soc Pathol Exot Filiales 1981;74:490-9.
24. Nakounne E, Selekon B, Morvan J. Microbiological surveillance: viral hemorrhagic fever in Central African Republic: current serological data in man [in French]. Bull Soc Pathol Exot 2000;93:340-7.
25. Nasidi A, Monath TP, DeCock K et al. Urban yellow fever epidemic in western Nigeria, 1987. Trans R Soc Trop Med Hyg 1989;83:401-6.
26. Thonnon J, Spiegel A, Diallo M et al. Yellow fever outbreak in Kaffrine, Senegal 1996: epidemiological and entomological findings. Trop Med Int Health 1998;3:872-7.
27. Pan American Health Organization. Present status of yellow fever: memorandum from a PAHO meeting. Bull World Health Organ 1986;64:511.
28. Herve JP, Germain M, Mouchet J et al. Monitoring Aedes aegypti indices in the Central African Empire, 1972-1976 [in French]. Cah ORSTOM Ser Ent Med Parasitol 1978;16:55-62.
29. Diemer JM, Herve JP, Geoffroy B et al. Monitoring Aedes aegypti Indices in the Central African Republic During the Years 1977-1980 [in French]. Bangui, Central African Republic: Institut Pasteur; 1982.
30. Chippaux-Hyppolite C, Chippaux A. Use of microtiter Takatsy for serological study of arboviruses in the Central African Republic [in French]. Med Trop (Mars) 1968;28:796-801.
31. World Health Organization. Global alert and response (GAR): yellow fever. [2010-2013]. http://www.who.int/csr/don/archive/disease/yellow_fever/en/[accessed2 December 2013].